People in England who suffer from the ultra-rare Morquio A syndrome should in future be able to access the only drug for their condition after a ground-breaking agreement was reached between NHS England and the manufacturer. NHS England has successfully negotiated a deal on elosulfase alfa (brand name Vimizim) with manufacturers BioMarin Pharma. The five […]
This vacancy is no longer available. NHS England is committed to ensuring that public and patient voices are at the centre of shaping our healthcare services. Every level of our commissioning system needs to be informed by insightful methods of listening to those who use and care about our services to inform service development. NHS […]
NHS England has today published an interim clinical commissioning policy on the use of adalimumab for children with severe refractory uveitis, recommending its use for patients who meet the clinical criteria it sets out. This policy will benefit children for whom uveitis threatens their sight, and for whom other treatments have proven ineffective. A policy […]
NHS England is committed to ensuring that public and patient voices are at the centre of shaping our healthcare services. Every level of our commissioning system needs to be informed by insightful methods of listening to those who use and care about our services to inform service development. There are a range of opportunities for […]
NHS England has today (2 July) set out its planned investment decisions for certain specialised services as part of its annual commissioning round. The decision follows a three-month public consultation on the principles and processes NHS England will follow when making investment decisions. Feedback from the consultation has helped inform the way these decisions have […]
Health leaders urged to work together to tackle issues faced by transgender and non-binary people across NHS services. NHS England is spearheading a collective drive to improve the experience of transgender and non-binary people when accessing health and care services. The body has called an urgent symposium for 30 June, bringing partners from across the […]
This article has been amended to better reflect the policy document. NHS England agrees funding for new drug treatments for Hep C In what will be the NHS’ single largest investment in new treatments this year, NHS England has today (11 June 2015) announced the budget will be increased to £190 million for new virological […]
NHS England has today (24 March 2015) launched a 30 day public consultation on a number of clinical commissioning policies and service specifications for specialised services. The 33 policies, five service specifications and two other commissioning products (Chemotherapy algorithms for multiple myeloma and UK Genetic Testing Network new test recommendations) will be open to a 30 […]
NHS England today launches a new consultation about how it will prioritise which specialised services and treatments to invest in. Patient groups asked it to consult on changes to the principles and process by which it makes these decisions. NHS England directly commissions around 145 specialised services. In order to ensure the maximum number of […]
NHS England has launched a 12-week consultation on proposed changes to the way in which genetic laboratories are commissioned. The proposals aim to deliver services across England which can better meet advances in genomic technologies, whilst driving improvements in quality and patient outcomes. The proposed changes are set out in the new draft service specification, […]